tiprankstipranks
Trending News
More News >
Sundrug Co Ltd (JP:9989)
:9989
Advertisement

Sundrug Co (9989) Stock Statistics & Valuation Metrics

Compare
0 Followers

Total Valuation

Sundrug Co has a market cap or net worth of $498.44B. The enterprise value is ¥508.64B.
Market Cap$498.44B
Enterprise Value¥508.64B

Share Statistics

Sundrug Co has 119,331,184 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding119,331,184
Owned by Insiders
Owned by Institutions

Financial Efficiency

Sundrug Co’s return on equity (ROE) is 0.11 and return on invested capital (ROIC) is 9.81%.
Return on Equity (ROE)0.11
Return on Assets (ROA)0.07
Return on Invested Capital (ROIC)9.81%
Return on Capital Employed (ROCE)0.14
Revenue Per Employee120.36M
Profits Per Employee4.62M
Employee Count6,662
Asset Turnover1.81
Inventory Turnover6.06

Valuation Ratios

The current PE Ratio of Sundrug Co is 15.9. Sundrug Co’s PEG ratio is 2.88.
PE Ratio15.9
PS Ratio0.61
PB Ratio1.83
Price to Fair Value1.83
Price to FCF63.83
Price to Operating Cash Flow55.90
PEG Ratio2.88

Income Statement

In the last 12 months, Sundrug Co had revenue of 801.81B and earned 30.75B in profits. Earnings per share was 262.90.
Revenue801.81B
Gross Profit204.09B
Operating Income44.50B
Pretax Income43.57B
Net Income30.75B
EBITDA61.02B
Earnings Per Share (EPS)262.90

Cash Flow

In the last 12 months, operating cash flow was 0.00 and capital expenditures 0.00, giving a free cash flow of 0.00 billion.
Operating Cash Flow0.00
Free Cash Flow0.00
Free Cash Flow per Share0.00

Dividends & Yields

Sundrug Co pays an annual dividend of ¥65, resulting in a dividend yield of 3.04%
Dividend Per Share¥65
Dividend Yield3.04%
Payout Ratio98.01%
Free Cash Flow Yield
Earnings Yield

Stock Price Statistics

Beta0.34
52-Week Price Change7.30%
50-Day Moving Average4.50K
200-Day Moving Average4.31K
Relative Strength Index (RSI)28.10
Average Volume (3m)237.21K

Important Dates

Sundrug Co upcoming earnings date is Nov 14, 2025, TBA (Confirmed).
Last Earnings DateAug 14, 2025
Next Earnings DateNov 14, 2025
Ex-Dividend DateSep 29, 2025

Financial Position

Sundrug Co as a current ratio of 1.69, with Debt / Equity ratio of 14.34%
Current Ratio1.69
Quick Ratio0.92
Debt to Market Cap0.08
Net Debt to EBITDA-0.43
Interest Coverage Ratio271.32

Taxes

In the past 12 months, Sundrug Co has paid 12.82B in taxes.
Income Tax12.82B
Effective Tax Rate0.29

Enterprise Valuation

Sundrug Co EV to EBITDA ratio is 7.64, with an EV/FCF ratio of 60.42.
EV to Sales0.58
EV to EBITDA7.64
EV to Free Cash Flow60.42
EV to Operating Cash Flow11.32

Balance Sheet

Sundrug Co has $62.98B in cash and marketable securities with $44.22B in debt, giving a net cash position of $18.77B billion.
Cash & Marketable Securities$62.98B
Total Debt$44.22B
Net Cash$18.77B
Net Cash Per Share$157.25
Tangible Book Value Per Share$2.23K

Margins

Gross margin is 25.45%, with operating margin of 5.55%, and net profit margin of 3.84%.
Gross Margin25.45%
Operating Margin5.55%
Pretax Margin5.43%
Net Profit Margin3.84%
EBITDA Margin7.61%
EBIT Margin5.45%

Analyst Forecast

The average price target for Sundrug Co is $5,366.38, which is 11.43% higher than the current price. The consensus rating is Moderate Buy
Price Target$5,366.38
Price Target Upside26.92% Upside
Analyst ConsensusModerate Buy
Analyst Count3
Revenue Growth Forecast6.64%
EPS Growth Forecast6.38%

Scores

Smart ScoreN/A
AI Score
What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis